Literature DB >> 7560232

Gingival crevicular stromelysin, collagenase and tissue inhibitor of metalloproteinases levels in healthy and diseased sites.

A Haerian1, E Adonogianaki, J Mooney, J P Docherty, D F Kinane.   

Abstract

The ability of stromelysin (SL), fibroblast-type collagenase (FIB-CL) and tissue inhibitor of metalloproteinases (TIMP), to differentiate between healthy, gingivitis and periodontitis sites was investigated. SL and FIB-CL are members of a family of enzymes which are capable of degrading most of the extracellular matrix macromolecules. Extracellular control of these enzymes is performed by TIMP. 40 patients each provided 3 GCF samples from healthy, gingivitis and periodontitis sites. GCF samples were collected by means of sterile paper strips. GCF samples were eluted into 500 microliters of assay buffer and assays for SL, FIB-CL and TIMP were performed by a sandwich ELISA. The mean amounts of SL and TIMP in diseased sites (gingivitis and periodontitis) were significantly higher than the mean amount of these GCF components in healthy sites (MANOVA p values were: 0.006 for SL and 0.001 for TIMP). GCF SL and TIMP differentiated healthy from diseased sites. Both SL and TIMP showed moderate correlation with clinical indices. FIB-CL was detectable in only 20.8% of all sites and did not correlate with disease status.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560232     DOI: 10.1111/j.1600-051x.1995.tb00797.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  8 in total

1.  Activation of neutrophil collagenase in periodontitis.

Authors:  R Romanelli; S Mancini; C Laschinger; C M Overall; J Sodek; C A McCulloch
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Clinical and biochemical effects of diode laser as an adjunct to nonsurgical treatment of chronic periodontitis: a randomized, controlled clinical trial.

Authors:  Mehmet Saglam; Alpdogan Kantarci; Niyazi Dundar; Sema S Hakki
Journal:  Lasers Med Sci       Date:  2012-11-16       Impact factor: 3.161

3.  IL-4 inhibition of IL-1 induced Matrix metalloproteinase-3 (MMP-3) expression in human fibroblasts involves decreased AP-1 activation via negative crosstalk involving of Jun N-terminal kinase (JNK).

Authors:  Mariah Chambers; Garrett Kirkpatrick; Michel Evans; Grzegorz Gorski; Sara Foster; Ruth C Borghaei
Journal:  Exp Cell Res       Date:  2013-04-19       Impact factor: 3.905

4.  Interleukin-4 suppresses IL-1-induced expression of matrix metalloproteinase-3 in human gingival fibroblasts.

Authors:  Kosunique Jenkins; Masoud Javadi; Ruth Carter Borghaei
Journal:  J Periodontol       Date:  2004-02       Impact factor: 6.993

5.  Interleukin-4 inhibition of interleukin-1-induced expression of matrix metalloproteinase-3 (MMP-3) is independent of lipoxygenase and PPARgamma activation in human gingival fibroblasts.

Authors:  Denise Stewart; Masoud Javadi; Mariah Chambers; Chad Gunsolly; Grzegorz Gorski; Ruth C Borghaei
Journal:  BMC Mol Biol       Date:  2007-02-23       Impact factor: 2.946

6.  Estimation of matrix metalloproteinase-3 levels in gingival crevicular fluid in periodontal disease, health and after scaling and root planing.

Authors:  N Ravindra Reddy; D Roopa; D S Madhu Babu; P Mohan Kumar; C Mahendra Raju; N Sarath Kumar
Journal:  J Indian Soc Periodontol       Date:  2012-10

7.  Comparison of matrix metalloproteinase-3 and tissue inhibitor of matrix metalloproteinase-1 levels in gingival crevicular fluid in periodontal health, disease and after treatment: A clinico biochemical study.

Authors:  P Mohan Kumar; N Ravindra Reddy; A Deepa; D S Madhu Babu; A Kishore Kumar; Vinay Chavan
Journal:  Dent Res J (Isfahan)       Date:  2013-07

8.  Inflammatory mediator polymorphisms associate with initial periodontitis in adolescents.

Authors:  Anna Maria Heikkinen; Kaisa Kettunen; Leena Kovanen; Jari Haukka; Jessica Elg; Heidi Husu; Taina Tervahartiala; Pirkko Pussinen; Jukka Meurman; Timo Sorsa
Journal:  Clin Exp Dent Res       Date:  2016-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.